552 related articles for article (PubMed ID: 18413441)
1. EULAR recommendations for the management of large vessel vasculitis.
Mukhtyar C; Guillevin L; Cid MC; Dasgupta B; de Groot K; Gross W; Hauser T; Hellmich B; Jayne D; Kallenberg CG; Merkel PA; Raspe H; Salvarani C; Scott DG; Stegeman C; Watts R; Westman K; Witter J; Yazici H; Luqmani R;
Ann Rheum Dis; 2009 Mar; 68(3):318-23. PubMed ID: 18413441
[TBL] [Abstract][Full Text] [Related]
2. EULAR recommendations for the management of primary small and medium vessel vasculitis.
Mukhtyar C; Guillevin L; Cid MC; Dasgupta B; de Groot K; Gross W; Hauser T; Hellmich B; Jayne D; Kallenberg CG; Merkel PA; Raspe H; Salvarani C; Scott DG; Stegeman C; Watts R; Westman K; Witter J; Yazici H; Luqmani R;
Ann Rheum Dis; 2009 Mar; 68(3):310-7. PubMed ID: 18413444
[TBL] [Abstract][Full Text] [Related]
3. EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis.
Hellmich B; Flossmann O; Gross WL; Bacon P; Cohen-Tervaert JW; Guillevin L; Jayne D; Mahr A; Merkel PA; Raspe H; Scott DG; Witter J; Yazici H; Luqmani RA
Ann Rheum Dis; 2007 May; 66(5):605-17. PubMed ID: 17170053
[TBL] [Abstract][Full Text] [Related]
4. 2018 Update of the EULAR recommendations for the management of large vessel vasculitis.
Hellmich B; Agueda A; Monti S; Buttgereit F; de Boysson H; Brouwer E; Cassie R; Cid MC; Dasgupta B; Dejaco C; Hatemi G; Hollinger N; Mahr A; Mollan SP; Mukhtyar C; Ponte C; Salvarani C; Sivakumar R; Tian X; Tomasson G; Turesson C; Schmidt W; Villiger PM; Watts R; Young C; Luqmani RA
Ann Rheum Dis; 2020 Jan; 79(1):19-30. PubMed ID: 31270110
[TBL] [Abstract][Full Text] [Related]
5. European League Against Rheumatism (EULAR) Scleroderma Trial and Research group (EUSTAR) recommendations for the treatment of systemic sclerosis: methods of elaboration and results of systematic literature research.
Avouac J; Kowal-Bielecka O; Landewe R; Chwiesko S; Miniati I; Czirjak L; Clements P; Denton C; Farge D; Fligelstone K; Földvari I; Furst DE; Müller-Ladner U; Seibold J; Silver RM; Takehara K; Toth BG; Tyndall A; Valentini G; van den Hoogen F; Wigley F; Zulian F; Matucci-Cerinic M;
Ann Rheum Dis; 2009 May; 68(5):629-34. PubMed ID: 18957486
[TBL] [Abstract][Full Text] [Related]
6. [Recommendations of the European League Against Rheumatism (EULAR) for the treatment of "large-vessel vasculitides"].
Wipfler-Freissmuth E; Moosig F; Schirmer M
Z Rheumatol; 2009 May; 68(3):260, 262-3. PubMed ID: 19057884
[No Abstract] [Full Text] [Related]
7. EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis.
Peters MJ; Symmons DP; McCarey D; Dijkmans BA; Nicola P; Kvien TK; McInnes IB; Haentzschel H; Gonzalez-Gay MA; Provan S; Semb A; Sidiropoulos P; Kitas G; Smulders YM; Soubrier M; Szekanecz Z; Sattar N; Nurmohamed MT
Ann Rheum Dis; 2010 Feb; 69(2):325-31. PubMed ID: 19773290
[TBL] [Abstract][Full Text] [Related]
8. 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Giant Cell Arteritis and Takayasu Arteritis.
Maz M; Chung SA; Abril A; Langford CA; Gorelik M; Guyatt G; Archer AM; Conn DL; Full KA; Grayson PC; Ibarra MF; Imundo LF; Kim S; Merkel PA; Rhee RL; Seo P; Stone JH; Sule S; Sundel RP; Vitobaldi OI; Warner A; Byram K; Dua AB; Husainat N; James KE; Kalot MA; Lin YC; Springer JM; Turgunbaev M; Villa-Forte A; Turner AS; Mustafa RA
Arthritis Care Res (Hoboken); 2021 Aug; 73(8):1071-1087. PubMed ID: 34235871
[TBL] [Abstract][Full Text] [Related]
9. Does glucocorticosteroid-resistant large-vessel vasculitis (giant cell arteritis and Takayasu arteritis) exist and how can remission be achieved? A critical review of the literature.
Kötter I; Henes JC; Wagner AD; Loock J; Gross WL
Clin Exp Rheumatol; 2012; 30(1 Suppl 70):S114-29. PubMed ID: 22640655
[TBL] [Abstract][Full Text] [Related]
10. EULAR recommendations for the management of Behçet disease.
Hatemi G; Silman A; Bang D; Bodaghi B; Chamberlain AM; Gul A; Houman MH; Kötter I; Olivieri I; Salvarani C; Sfikakis PP; Siva A; Stanford MR; Stübiger N; Yurdakul S; Yazici H;
Ann Rheum Dis; 2008 Dec; 67(12):1656-62. PubMed ID: 18245110
[TBL] [Abstract][Full Text] [Related]
11. Recommendations of the Italian Society of Rheumatology for the treatment of the primary large-vessel vasculitis with biological agents.
Pipitone N; Olivieri I; Salvarani C;
Clin Exp Rheumatol; 2012; 30(1 Suppl 70):S139-61. PubMed ID: 22640657
[TBL] [Abstract][Full Text] [Related]
12. [Large vessel vasculitis: giant cell arteritis and Takayasu arteritis].
Petitpierre S; Bart PA; Leimgruber A; Spertini F; Prior J; Spertini F
Rev Med Suisse; 2007 Apr; 3(108):1056-60, 1062-3. PubMed ID: 17552258
[TBL] [Abstract][Full Text] [Related]
13. EULAR recommendations for the role of the nurse in the management of chronic inflammatory arthritis.
van Eijk-Hustings Y; van Tubergen A; Boström C; Braychenko E; Buss B; Felix J; Firth J; Hammond A; Harston B; Hernandez C; Huzjak M; Korandová J; Kukkurainen ML; Landewé R; Mezieres M; Milincovic M; Moretti A; Oliver S; Primdahl J; Scholte-Voshaar M; de la Torre-Aboki J; Waite-Jones J; Westhovens R; Zangi HA; Heiberg T; Hill J;
Ann Rheum Dis; 2012 Jan; 71(1):13-9. PubMed ID: 22039168
[TBL] [Abstract][Full Text] [Related]
14. EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR).
Kowal-Bielecka O; Landewé R; Avouac J; Chwiesko S; Miniati I; Czirjak L; Clements P; Denton C; Farge D; Fligelstone K; Földvari I; Furst DE; Müller-Ladner U; Seibold J; Silver RM; Takehara K; Toth BG; Tyndall A; Valentini G; van den Hoogen F; Wigley F; Zulian F; Matucci-Cerinic M;
Ann Rheum Dis; 2009 May; 68(5):620-8. PubMed ID: 19147617
[TBL] [Abstract][Full Text] [Related]
15. Systematic literature review informing the 2018 update of the EULAR recommendation for the management of large vessel vasculitis: focus on giant cell arteritis.
Monti S; Águeda AF; Luqmani RA; Buttgereit F; Cid M; Dejaco C; Mahr A; Ponte C; Salvarani C; Schmidt W; Hellmich B
RMD Open; 2019; 5(2):e001003. PubMed ID: 31673411
[TBL] [Abstract][Full Text] [Related]
16. EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).
Zhang W; Doherty M; Arden N; Bannwarth B; Bijlsma J; Gunther KP; Hauselmann HJ; Herrero-Beaumont G; Jordan K; Kaklamanis P; Leeb B; Lequesne M; Lohmander S; Mazieres B; Martin-Mola E; Pavelka K; Pendleton A; Punzi L; Swoboda B; Varatojo R; Verbruggen G; Zimmermann-Gorska I; Dougados M;
Ann Rheum Dis; 2005 May; 64(5):669-81. PubMed ID: 15471891
[TBL] [Abstract][Full Text] [Related]
17. Patient and rheumatologist perspectives on glucocorticoids: an exercise to improve the implementation of the European League Against Rheumatism (EULAR) recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases.
van der Goes MC; Jacobs JW; Boers M; Andrews T; Blom-Bakkers MA; Buttgereit F; Caeyers N; Choy EH; Cutolo M; Da Silva JA; Guillevin L; Holland M; Kirwan JR; Rovensky J; Saag KG; Severijns G; Webber S; Westhovens R; Bijlsma JW
Ann Rheum Dis; 2010 Jun; 69(6):1015-21. PubMed ID: 19762359
[TBL] [Abstract][Full Text] [Related]
18. Evidence-based recommendations for the management of ankylosing spondylitis: systematic literature search of the 3E Initiative in Rheumatology involving a broad panel of experts and practising rheumatologists.
Sidiropoulos PI; Hatemi G; Song IH; Avouac J; Collantes E; Hamuryudan V; Herold M; Kvien TK; Mielants H; Mendoza JM; Olivieri I; Østergaard M; Schachna L; Sieper J; Boumpas DT; Dougados M
Rheumatology (Oxford); 2008 Mar; 47(3):355-61. PubMed ID: 18276738
[TBL] [Abstract][Full Text] [Related]
19. European League Against Rheumatism/European Vasculitis Study Group recommendations for the management of vasculitis.
Villa-Forte A; ;
Curr Opin Rheumatol; 2010 Jan; 22(1):49-53. PubMed ID: 19823089
[TBL] [Abstract][Full Text] [Related]
20. Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations.
Aletaha D; Landewe R; Karonitsch T; Bathon J; Boers M; Bombardier C; Bombardieri S; Choi H; Combe B; Dougados M; Emery P; Gomez-Reino J; Keystone E; Koch G; Kvien TK; Martin-Mola E; Matucci-Cerinic M; Michaud K; O'Dell J; Paulus H; Pincus T; Richards P; Simon L; Siegel J; Smolen JS; Sokka T; Strand V; Tugwell P; van der Heijde D; van Riel P; Vlad S; van Vollenhoven R; Ward M; Weinblatt M; Wells G; White B; Wolfe F; Zhang B; Zink A; Felson D
Ann Rheum Dis; 2008 Oct; 67(10):1360-4. PubMed ID: 18791055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
